Gnomet (is that an anagram for MUPPET) stick around the deal for Trovax will be announced by the end of the first quarter. Recruitment for Trist is started and by June next year we will have preliminary data that will be impressive and then you will see further developements on trials for Trovax for other cancers.
2007 will be a great year for OXB not a time for bearish activity or for selling up.